DINOTO, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 1.297
AS - Asia 985
NA - Nord America 849
SA - Sud America 232
AF - Africa 67
Totale 3.430
Nazione #
RU - Federazione Russa 864
US - Stati Uniti d'America 804
SG - Singapore 467
BR - Brasile 192
CN - Cina 178
IT - Italia 117
HK - Hong Kong 109
VN - Vietnam 96
GB - Regno Unito 64
DE - Germania 51
IE - Irlanda 45
KR - Corea 37
FI - Finlandia 30
FR - Francia 28
CA - Canada 27
SE - Svezia 27
ZA - Sudafrica 20
JP - Giappone 19
AR - Argentina 18
TG - Togo 18
ID - Indonesia 16
BJ - Benin 15
NL - Olanda 14
PL - Polonia 14
BD - Bangladesh 12
IN - India 12
MX - Messico 12
AT - Austria 9
IQ - Iraq 8
ES - Italia 7
TR - Turchia 7
BE - Belgio 5
EC - Ecuador 5
MA - Marocco 5
PK - Pakistan 5
UA - Ucraina 5
CL - Cile 4
LT - Lituania 4
PE - Perù 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JM - Giamaica 3
LU - Lussemburgo 3
PY - Paraguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
KE - Kenya 2
LB - Libano 2
OM - Oman 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ML - Mali 1
NP - Nepal 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.430
Città #
Moscow 319
Singapore 231
Ashburn 149
Hong Kong 109
Dallas 91
Chandler 77
Beijing 47
Los Angeles 47
Dublin 41
Ho Chi Minh City 38
New York 33
London 27
Munich 23
The Dalles 23
São Paulo 21
Hanoi 19
Redondo Beach 19
Lomé 18
Buffalo 16
Cotonou 15
Tokyo 14
Warsaw 14
Montreal 13
Helsinki 12
Milan 12
Lappeenranta 11
Phoenix 11
Denver 10
Jakarta 10
Johannesburg 10
Santa Clara 10
Verona 10
Orem 9
Mexico City 8
Poplar 8
Bologna 7
Chicago 7
Rome 7
Atlanta 6
Cape Town 6
Frankfurt am Main 6
Haiphong 6
Houston 6
Kent 6
Lawrence 6
Naples 6
Princeton 6
Seattle 6
Brasília 5
Brooklyn 5
Brussels 5
Campinas 5
Florence 5
Fortaleza 5
Guangzhou 5
Nuremberg 5
Rio de Janeiro 5
Seoul 5
Sindelfingen 5
Toronto 5
Washington 5
Belo Horizonte 4
Boston 4
Casablanca 4
Columbus 4
Da Nang 4
Stockholm 4
Tianjin 4
Treviso 4
Turku 4
Udine 4
Venice 4
Xi'an 4
Amsterdam 3
Baghdad 3
Bauru 3
Berlin 3
Bexley 3
Biên Hòa 3
Boardman 3
Bắc Ninh 3
Delhi 3
Guayaquil 3
Lima 3
Manassas 3
Manchester 3
Nova Iguaçu 3
Santiago 3
Southend 3
Vienna 3
Ankara 2
Bochum 2
Cabo Frio 2
Cairo 2
Campos dos Goytacazes 2
Caxias do Sul 2
Council Bluffs 2
Cursi 2
Córdoba 2
Duque de Caxias 2
Totale 1.790
Nome #
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 204
Autoimmune encephalitis misdiagnosis and mimics 124
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 118
Is there a correlation between MOGAD and SARS-CoV-2 infection? 118
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 117
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 113
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 109
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 100
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 100
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 99
Autoimmune dementia 97
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 95
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 94
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 94
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 90
Investigating the association between neoplasms and MOG antibody-associated disease 88
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 86
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 85
Fatigue in Multiple Sclerosis: a resting-state EEG microstate study 85
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 84
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 83
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses 82
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 81
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 78
Complement activation profiles predict clinical outcomes in myelin oligodendrocyte glycoprotein antibody-associated disease 74
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder 72
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses 69
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? 69
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease 66
Diagnosing an unusual case of myelitis and diabetes insipidus through skin biopsies 64
Treatment options in refractory autoimmune encephalitis 63
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis 63
Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: A retrospective case series and a systematic review of reported cases 63
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 61
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 61
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder 60
Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study 57
Serum Levels of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Correlate with Disease Severity in Patients with West Nile Virus Infection 54
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 44
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 38
Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease 36
Epstein-Barr virus infection in patients with MOGAD 27
Unveiling Disability Accrual Mechanisms in AQP4-IgG-Positive NMOSD 26
Totale 3.491
Categoria #
all - tutte 13.275
article - articoli 13.275
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 0 0 0 0 0 0 2 13 9 7
2022/2023236 6 18 13 32 18 69 4 15 32 6 13 10
2023/2024294 12 15 23 30 21 48 14 25 12 14 56 24
2024/2025856 48 27 34 121 48 44 49 50 136 71 88 140
2025/20262.074 184 160 144 517 920 149 0 0 0 0 0 0
Totale 3.491